NYSEARCA:REVS Columbia Research Enhanced Value ETF (REVS) Price, Holdings, & News $25.67 -0.34 (-1.31%) As of 02/21/2025 04:10 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOwnershipRatings About Columbia Research Enhanced Value ETF (NYSEARCA:REVS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get REVS alerts:Sign Up Key Stats Today's Range$25.66▼$25.9150-Day Range$24.49▼$26.1152-Week Range$22.44▼$27.03Volume5,789 shsAverage Volume7,688 shsMarket Capitalization$46.21 millionAssets Under Management$65.41 millionDividend Yield1.87%Net Expense Ratio0.19%Aggregate RatingModerate Buy ETF OverviewThe Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000 Value Index. REVS index uses multifactor selection and market cap weighting. REVS was launched on Sep 25, 2019 and is managed by Columbia.Read More… Columbia Research Enhanced Value ETF ExpensesTypeREVSLarge Cap ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.19%0.58%0.56%0.51%0.53%Other Expenses0.00%0.30%0.50%0.57%0.53%Total Expense0.19%0.65%0.72%0.73%0.71%Fee Waiver0.00%-0.25%-0.50%-0.66%-0.56%Net Expense0.19%0.62%0.62%0.58%0.60% Receive REVS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Columbia Research Enhanced Value ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address REVS ETF News HeadlinesColumbia Research Enhanced Real Estate ETFDecember 23, 2024 | investing.comREVS Columbia Research Enhanced Value ETFOctober 17, 2024 | seekingalpha.comNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry.February 22, 2025 | Brownstone Research (Ad)FEPY ETF: Combining Income and Growth Opportunities for Canadian InvestorsOctober 2, 2024 | theglobeandmail.comColumbia Thermostat A CTFAXAugust 14, 2024 | morningstar.comThe Zacks Analyst Blog Highlights IBM, Amazon.com and MicrosoftAugust 13, 2024 | uk.finance.yahoo.comSee More Headlines REVS ETF - Frequently Asked Questions How have REVS shares performed this year? Columbia Research Enhanced Value ETF's stock was trading at $24.73 at the beginning of the year. Since then, REVS stock has increased by 3.8% and is now trading at $25.67. View the best growth stocks for 2025 here. Who are Columbia Research Enhanced Value ETF's major shareholders? Top institutional shareholders of Columbia Research Enhanced Value ETF include LPL Financial LLC (92.03%), NewEdge Advisors LLC (5.88%), Ruggaard & Associates LLC (2.77%) and Frederick Financial Consultants LLC (2.17%). How do I buy shares of Columbia Research Enhanced Value ETF? Shares of REVS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Columbia Research Enhanced Value ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Columbia Research Enhanced Value ETF investors own include The GEO Group (GEO), Global X SuperDividend REIT ETF (SRET), BlackRock Capital Investment (BKCC), British American Tobacco (BTI), Energy Transfer (ET), International Business Machines (IBM) and Annaly Capital Management (NLY). Fund Details IssuerColumbia Fund NameColumbia Research Enhanced Value ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:REVS Inception Date9/25/2019 Fund ManagerChristopher Lo, Jason Wang WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkBeta Advantage Research Enhanced U.S. Value Index CategorySize and Style FocusLarge Cap Development LevelDeveloped Markets RegionNorth America Number of Holdings318 Fund Statistics Assets Under Management$65.41 million Average Daily Volume$0.00 Discount/Premium-0.02% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorColumbia Management Investment Advisers, LLC CustodianThe Bank of New York Mellon Corporation DistributorALPS Distributors, Inc. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerJane Street Options OptionableN/A Short Interest9,300 shs Miscellaneous Outstanding Shares1,800,000Beta0.76 Creation Unit50,000 Creation Fee$500.00 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?Get This Free Report Top 10 REVS HoldingsJPMorgan Chase & Co. (NYSE:JPM)Holding Weight: 6.01%Cisco Systems (NASDAQ:CSCO)Holding Weight: 3.60%Philip Morris International (NYSE:PM)Holding Weight: 2.84%Exxon Mobil (NYSE:XOM)Holding Weight: 2.67%Bank of America (NYSE:BAC)Holding Weight: 2.58%Bristol-Myers Squibb (NYSE:BMY)Holding Weight: 2.48%Medtronic (NYSE:MDT)Holding Weight: 2.45%Wells Fargo & Company (NYSE:WFC)Holding Weight: 2.29%RTX (NYSE:RTX)Holding Weight: 1.90%Caterpillar (NYSE:CAT)Holding Weight: 1.75%Full Holdings DetailsREVS Sector ExposureREVS Industry Exposure This page (NYSEARCA:REVS) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Columbia Research Enhanced Value ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Columbia Research Enhanced Value ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.